• THIS NEW ULTRASENSITIVE METHOD HAS THE LOWEST MARGIN OF ERROR DUE TO ITS EXTREMELY HIGH SENSITIVITY, PROVIDING HIGHER ACCURACY THAN IS COMMERCIALLY AVAILABLE.

• The 3rd Generation PSA test, because of its extremely high sensitivity, detects levels of PSA in post radical prostatectomy patients. However, non prostatic PSA can be found in female sera as well that may be of great importance in breast, ovarian, and other tumors. Unlike for men, the higher the 3rd Generation PSA is in breast cancer patients, the better is the prognosis.

• Recent clinical research has further confirmed the role of PSA in the management of various non prostatic cancers, most significantly breast tumors.

• Immunofluorometric studies were conducted to analyze serum samples from post radical prostatectomy and breast cancer patients. As a result, very low PSA levels were found in post radical prostatectomy patients, especially by the utilization of the 3rd Generation PSA test. The exceptionally high sensitivity of the test, used by American Metabolic Laboratories, 0.003 ng/mL, allows earlier detection of PSA after prostatectomy. The traditional cutoff value of 4.0, deemed normal, may terribly miss prostate cancer warning

• Women with breast cancer demonstrated a favorable prognosis when PSA was present in tumor cystol, i.e. PSA-positive tumors showed improved disease-free and overall survival over women with PSA-negative tumors. It has been reported also that PSA levels in nipple aspirate were inversely correlated with breast cancer risk.
• Traditional PSA Normal Values are :0.0 - 4.0
• 3rd Gen PSA Normal Values for men are: 0.00 - 2.80

• Specimen Requirements : 200 - 500 µL serum or aspirate

|  Blood Tests  |  Home  |  About Our Doctor  |  Contact Us  |